We are a patient-focused genomic medicines company driven by science and our ambition to disrupt the field of ophthalmology.

Join our growing, global team and contribute to the discovery & development of cutting-edge therapies for the treatment of ocular diseases.

Contact us at

Current Vacancies


SparingVision’s lead product, SPVN06, is a breakthrough gene therapy approach targeting Inherited Retinal Diseases (IRDs).

Learn More